REQUEST A DEMO
Total
USD $0.00
Search more companies

Biogenesis Bago Colombia S.A.S (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Biogenesis Bago Colombia S.A.S Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Biogenesis Bago Colombia S.A.S is an enterprise in Colombia, with the main office in Bogota D.C.. The company operates in the Pharmacies and Drug Stores sector. Biogenesis Bago Colombia S.A.S was incorporated on August 02, 2016. It currently has a total number of 15 (2026) employees. The latest financial highlights indicate a net sales revenue increase of 115.77% in 2025. There was a total growth of 69.77% in Biogenesis Bago Colombia S.A.S’s total assets over the same period. The net profit margin of Biogenesis Bago Colombia S.A.S decreased by 20.2% in 2025.

Headquarters
Cr 19 # 118-30 Of 211 Centro Negocios Av 19
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Biogenesis Bago Colombia S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Biogenesis Bago Colombia S.A.S report to view the information.
Financial Auditors:
Purchase the Biogenesis Bago Colombia S.A.S report to view the information.
Incorporation Date:
August 02, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Biogenesis Bago Colombia S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
115.77%
Total Operating Revenue
115.77%
Operating Profit
N/A
Net Profit/Loss for the Period
-36.89%
Total Assets
69.77%
Total Equity
5.79%
Operating Profit Margin
N/A
Net Profit Margin
-20.2%
Return on Equity (ROE)
20.86%
Quick Ratio
-0.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?